Harry Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Richard L. Cassin Editor at Large

Elizabeth K. Spahn Editor Emeritus 

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

FCPA Blog Daily News

Entries in Bio-Rad (11)


Here's what the Bio-Rad ruling means for FCPA retaliation

Federal court opinions interpreting the FCPA are rare indeed -- my informal tally puts the number at a dozen or so since 1977. This week, that number increased by one, thanks to the 9th Circuit’s opinion in Wadler v. Bio-Rad Laboratories, which grows out of Bio-Rad’s $55 million FCPA settlement in 2014. 

Click to read more ...


Practice Note: How Bio-Rad’s old FCPA settlement became a ‘risk factor’

You would expect investors to be pleased and optimist when their company resolves an FCPA case by paying relatively moderate penalties and landing a DOJ non-prosecution agreement.

Click to read more ...


FCPA whistleblower: Former Bio-Rad GC awarded $10 million for retaliatory firing

A federal jury in San Francisco took just three hours Monday to decide that Bio-Rad Laboratories Inc. retaliated against former general counsel Sanford “Sandy” Wadler for reporting FCPA violations.

Click to read more ...


Pleasure or pain? Voluntary FCPA disclosure and cooperation

In our recent report, Trends and Developments in Anti-Corruption Enforcement, we analyze major anti-corruption resolutions in 2014 and look ahead to what we expect in 2015.

Click to read more ...


Avon disgorgement lands on top ten list

Image courtesy of AvonAvon's $135 million settlement with the DOJ and SEC earlier this month included a disgorgement to the SEC with interest that ranks 8th on our list of the biggest FCPA disgorgements.

Click to read more ...


Vietnam puts Bio-Rad purchases under review, asks U.S. to share probe info

Image courtesy of Bio-Rad LaboratoriesVietnam's Ministry of Health Thursday ordered a review of purchases of medical equipment manufactured by Seattle-based Bio-Rad Laboratories, Inc., following the company's $55 million settlement of FCPA offenses, which included allegations of bribery in Vietnam.

Click to read more ...


Bio-Rad cracks the disgorgement top ten list

Bio-Rad Laboratories paid a total of $55 million Monday to settle FCPA offenses. About $40 million of that went to the SEC as disgorgement. That payment landed tenth on our list of the biggest FCPA-related disgorgements.

Click to read more ...


Bio-Rad pays $55 million to settle FCPA offenses

California-based life science company Bio-Rad Laboratories agreed Monday to pay a total of $55 million to settle DOJ and SEC allegations that subsidiaries made improper payments to foreign officials in Russia, Vietnam, and Thailand to win business

Click to read more ...


Bio-Rad lifts FCPA settlement reserve to $35 million

Bio-Rad Laboratories Inc. said in its annual report Tuesday that it has added $15 million to its reserve for a potential Foreign Corrupt Practices Act settlement, bringing the total to $35 million.

Click to read more ...


Job: Compliance Aggregation Analyst

Job Title: Compliance Aggregation Analyst

Company: Bio-Rad

Location: Hercules, CA

Click to read more ...


Docs collect billions for drug promos

ProPublica ran an exposé this week about big bucks for doctors who promote products for drug companies.

Click to read more ...